Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Incorporation of bevacizumab in the primary treatment of ovarian cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Incorporation of bevacizumab in the primary treatment of ovarian cancer.
Incorporation of bevacizumab in the primary treatment of ovarian cancer. N Engl J Med. 2011 Dec 29; 365(26):2473-83.
View in:
PubMed
subject areas
Adult
Adult
Aged
Aged
Aged, 80 and over
Aged, 80 and over
Angiogenesis Inhibitors
Angiogenesis Inhibitors
Antibodies, Monoclonal, Humanized
Antibodies, Monoclonal, Humanized
Antineoplastic Combined Chemotherapy Protocols
Antineoplastic Combined Chemotherapy Protocols
Bevacizumab
Bevacizumab
Carboplatin
Carboplatin
Combined Modality Therapy
Combined Modality Therapy
Disease-Free Survival
Disease-Free Survival
Double-Blind Method
Double-Blind Method
Female
Female
Humans
Humans
Middle Aged
Middle Aged
Neoplasms, Glandular and Epithelial
Neoplasms, Glandular and Epithelial
Ovarian Neoplasms
Ovarian Neoplasms
Paclitaxel
Paclitaxel
Quality of Life
Quality of Life
Survival Analysis
Survival Analysis
Young Adult
Young Adult
authors with profiles
Robert S Mannel